Results 91 to 100 of about 12,119 (223)

Brain Involvement in Neuromyelitis Optica Spectrum Disorders [PDF]

Archives of Neurology, 2011
Neuromyelitis optica spectrum disorders (NMOSDs) are severe inflammatory demyelinating disorders of the central nervous system. Brain involvement is increasingly recognized.To study brain involvement in NMOSDs among Hong Kong Chinese patients.Retrospective study of patients with NMOSDs.Tertiary medical center in Hong Kong.
Tse, CT, Lee, RLC, Chung, CP, Kwan, JSC, Ho, PWL, Ho, JWM, Chan, KH   +6 more
openaire   +4 more sources

Pediatric Therapeutic Plasma Exchange: Characterization of Practice, Epidemiology, and Safety Profile at a Children's Hospital in the United States

Journal of Clinical Apheresis, Volume 41, Issue 3, June 2026.
ABSTRACT There is a need to better understand the indications and safety profiles for therapeutic plasma exchange (TPE) in children. We aimed to assess pediatric TPE practice at a large academic center by retrospective chart review from 2011 to 2022. Patient demographics and clinical information including American Society for Apheresis (ASFA) category ...
Benjamin C. Lee, Brian D. Adkins, Ayda Javanbakht, Hung S. Luu, Daniel K. Noland   +4 more
wiley   +1 more source

Soroprevalência do anticorpo NMO-IgG em pacientes brasileiros com neuromielite óptica [PDF]

, 2008
OBJECTIVE: To determine the seroprevalence of neuromyelitis optica antibody (NMO)-IgG in Brazilian patients with clinical diagnosis of relapsing neuromyelitis optica, also known as Devic's disease.
ADONI, Tarso, CALLEGARO, Dagoberto, KOK, Fernando, LINO, Angelina Maria Martins, MARCHIORI, Paulo Eurípedes   +4 more
core   +2 more sources

Detection of Diagnostic Antibodies in Immune‐Mediated Diseases: A Focus on Antigens and Technologies

ChemBioChem, Volume 27, Issue 9, 14 May 2026.
This review explores autoantibody detection in immune‐mediated diseases, highlighting autoantigens including post‐translational modifications. We compared enzyme‐linked immunosorbent assay and indirect immunofluorescence with automated chemiluminescence platforms.
Silvia Bracci, Feliciana Real‐Fernandez, Federico Pratesi, Francesca Nuti, Paolo Rovero, Anna Maria Papini   +5 more
wiley   +1 more source

Targeted therapy for neuromyelitis optica spectrum disorders

Chinese Journal of Contemporary Neurology and Neurosurgery, 2020
Neuromyelitis optica spectrum disorders (NMOSDs) have the characteristics of high relapse rate and high disability rate. The neurological deficits would become more and more serious with increasing relapse.
Yang⁃tai GUAN
doaj  

Area Postrema Syndrome: A Lesser Known Variant of Neuromyelitis Optica Spectrum Disorder

Indian Journal of Medical Specialities, 2019
One of the most specific presentations of neuromyelitis optica spectrum disorders (NMOSDs) is area postrema syndrome (APS). Although NMOSDs are now being increasingly encountered, APS is rarely reported in literature.
Gaurav Kumar Mittal, Shilpa Sekhar, John Jacob Mathew, Jennifer Singhdev   +3 more
doaj   +1 more source

Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. [PDF]

, 2014
Neuromyelitis optica (NMO) is an autoimmune disease of the CNS that is characterized by inflammatory demyelinating lesions in the spinal cord and optic nerve, potentially leading to paralysis and blindness.
A Bar-Or, A Davies, A Iyer, A Jacob, A Jacob, A Jacob, A Jacob, A McKeon, A Nagaishi, A Rossi, A Uzawa, A Warth, AE Damiano, Alan S. Verkman, AMC Faria, B Banwell, B Bielekova, B Bourre, B Weinstock-Guttman, BA Cree, BC Kieseier, BG Weinshenker, BL Raveendra, BM Greenberg, BM Greenberg, C Costanzi, C Trebst, C Wrzos, CF Lucchinetti, CH Polman, D Ricklin, D Ricklin, D Yuksel, DB Bichuetti, DB Bichuetti, DG Brum, DJ Kimbrough, DK Sato, DM Wingerchuk, DM Wingerchuk, E Gomori, EW Gelfand, F Shimizu, G Pentón-Rol, GG Illei, GS Bedi, H Kita, H Merle, H Wang, H Wen, H Yaguchi, H Zephir, H Zhang, H Zhang, HH Wang, HL Pellkofer, HL Pellkofer, HL Pellkofer, HM Reeves, I Ayzenberg, I Kleiter, I Kleiter, I Nakashima, J Bakker, J Fagius, J Kitley, J Kitley, J Kitley, J Kitley, J Kitley, J Kitley, J Palace, J Ratelade, J Ratelade, J Ratelade, J Ratelade, J Shimizu, JA Cabrera-Gomez, Jeffrey L. Bennett, JH Min, JL Bennett, JM Crane, JM Tillema, JR Faulkner, JS Wu, K Iwata, K Kawabata, K Miyamoto, K Okada, K Rostasy, K Sugita, KR Carson, L Elsone, L Tradtrantip, L Tradtrantip, L Tradtrantip, L Tradtrantip, LA Lewis, M Araki, M Barnett, M Bonnan, M Bonnan, M Botto, M Bradl, M Collin, M De Falco, M Keegan, M Koga, M Matiello, M Matiello, M Pohl, M Reindl, M Ringelstein, M Varrin-Doyer, MA Mealy, MA Sahraian, Marios C. Papadopoulos, MC Papadopoulos, MJ Magraner, N Asavapanumas, N Asavapanumas, N Asgari, N Chihara, N Chihara, N Muls, O Hammer, P Cabre, P Huppke, P Imbach, PF Zipfel, PJ Barnes, PW Phuan, PW Phuan, PW Phuan, R Deschamps, R Reuss, RC Axtell, RE Young, RR Voskuhl, S Izaki, S Jacob, S Jarius, S Jarius, S Jarius, S Jarius, S Jarius, S Jarius, S Jarius, S Kim, S Mader, S Mihai, S Saadoun, S Saadoun, S Saadoun, S Saadoun, S Saadoun, S Saadoun, S Watanabe, S-H Kim, S-H Kim, S-H Kim, S-H Kim, SH Kim, SJ Pittock, SR Hinson, SR Hinson, SR Hinson, SR Kalluri, T Hosokawa, T Kageyama, T Matsuoka, T Matsushita, T Vincent, TE Lotze, TF Tedder, UC Linhares, V Papayannopoulos, VA Lennon, VA Lennon, VT Chu, W Kim, Y Li, Y Warabi, YD Fragoso   +183 more
core   +1 more source

Reply to Letter: “Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring” by Saccà and Pelto Regarding “Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab”

Annals of Clinical and Translational Neurology, EarlyView.
Lea Gerischer, Jutta Schroeder‐Braunstein, Guido Wabnitz, Andreas Meisel   +3 more
wiley   +1 more source

Multidisciplinary rehabilitation for adults with neuromyelitis optica spectrum disorders: A pilot study

Journal of Rehabilitation Medicine, 2019
Objective: To provide detailed data on the effects of multidisciplinary rehabilitation for patients with neuromyelitis optica spectrum disorder with moderate to severe disability. Design: A pilot randomized control study.
Dong-Mei Suo, Lin-lin Liu, Kun Jia, Lin-jie Zhang, Li-Min Li, Jing Wang, Yuan Qi, Hai-jie Liu, Chun-Xiao Wan, Li Yang   +9 more
doaj   +1 more source

Baló’s concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures [PDF]

, 2018
Background: Baló’s concentric sclerosis (BCS) is a rare inflammatory demyelinating disorder of the central nervous system characterised by concentric layers of demyelination.
Behrens, J. R., Haas, J., Jarius, S., Paul, F., Wanner, J., Wildemann, B., Würthwein, C.   +6 more
core   +3 more sources